Wenfei Yan

A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.

D. Murrell, J. Frew, M. Marinkovich, 2013, Journal of the American Academy of Dermatology.

Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.

J. McGrath, I. Leigh, F. Hogg, 2012, Cancer research.

A Review of 52 Pedigrees with Epidermolysis Bullosa Simplex Identifying Ten Novel Mutations in KRT5 and KRT14 in Australia.

D. Murrell, John C. Su, A. Harris, 2017, Acta dermato-venereologica.

Future Therapies for Epidermolysis Bullosa

D. Murrell, Jae Hwan Kim, Wenfei Yan, 2015 .

Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa.

D. Murrell, W. Yan, Wenfei Yan, 2010, Dermatologic clinics.